Sunrun Reports Third Quarter 2017 Financial Results
Nov 08, 2017 21:02 pm UTC| Business
Unlevered NPV of $1.15 per watt in Q3 2017, the highest in the company’s historyNet Present Value of $93 million created in Q3 2017, an increase of 21% Year-Over-YearNet Earning Assets of $1.2 billion, an increase of 24%...
Noble Energy Signs Agreement to Divest Non-Core DJ Basin Acreage
Nov 08, 2017 21:02 pm UTC| Business
Houston, Nov. 08, 2017 -- Noble Energy, Inc. (NYSE: NBL) (“Noble Energy” or “the Company”) today announced that it has signed a definitive agreement with SRC Energy Inc. to divest approximately 30,200 net acres from the...
Amdocs Limited Reports Fourth Quarter Fiscal 2017 Results
Nov 08, 2017 21:02 pm UTC| Business
Record Quarterly Revenue of $980M Expects Fiscal 2018 GAAP Diluted EPS Growth of 3.0%-9.0% and Non-GAAP Diluted EPS Growth of 4.0%-8.0% YoY Additional $800M Share Repurchase Program Authorized Quarterly Cash Dividend...
Intrinsyc Reports Fourth Sequential Quarter of Revenue Growth
Nov 08, 2017 21:02 pm UTC| Business
VANCOUVER, British Columbia, Nov. 08, 2017 -- Intrinsyc Technologies Corporation (TSX:ITC) (OTC:ISYRF) (“Intrinsyc” or the “Company”), a leading provider of solutions for the development of embedded and IoT products,...
Laureate Education, Inc. Announces Appointment of Chief Financial Officer
Nov 08, 2017 21:01 pm UTC| Business
BALTIMORE, Nov. 08, 2017 -- Today, Laureate Education, Inc. (Nasdaq:LAUR), the global leader in higher education, announced the appointment of Jean-Jacques Charhon as its new Executive Vice President for Finance and...
Conifer Holdings Reports 2017 Third Quarter Financial Results
Nov 08, 2017 21:01 pm UTC| Business
BIRMINGHAM, Mich., Nov. 08, 2017 -- Conifer Holdings, Inc. (Nasdaq:CNFR) (“Conifer” or the “Company”) today announced results for the third quarter ended September 30, 2017. Financial Initiatives Implemented During...
Cara Therapeutics to Present at November Investor Conferences
Nov 08, 2017 21:01 pm UTC| Business
STAMFORD, Conn., Nov. 08, 2017 -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus and pain by selectively...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update